Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...

The biopsy devices market is expanding rapidly, driven by rising cancer cases, technological advancements, and minimally invasive procedures. Demand for precision diagnostics fuels innovation.” - ...

Pre-market: 7:10:59 am GMT-5 ...

The update comes about six weeks after an early alert flagged reports of 120 injuries and one death linked to reprocessing of the device. CEO Scott Whitaker said “an exemption was provided for most ...